HIGHLIGHTS
- who: Cheol Ho Park and Tae-Hyun Yoo from the Department of Internal Medicine, Institute of Disease Research, College of Medicine, Yonsei University, Seodaemun-gu, Seoul, Republic of Korea have published the paper: TGF- Inhibitors for Therapeutic Management of Kidney Fibrosis, in the Journal: Pharmaceuticals 2022, 1485 of /2022/
- what: As outlined in this review, TGF-u03b2 plays an imperative role in kidney fibrosis via canonical and non-canonical signaling pathways, and several TGF-u03b2 inhibitors have been extensively investigated.
- how: The authors developed a novel BMP-7 delivery system and reported the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.